We don’t talk enough about what doesn’t scale. Which is ironic, because we talk about scale constantly. Scale is the ...
Guardant Health posts strong Q3 results and lifts outlook. See insights on GH stock's growth, financials, and what’s driving ...
TransMedics delivered solid year-over-year growth in Q3, despite seasonal weakness and concerns over U.S. liver market saturation. Learn more about TMDX stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback